Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander R Abbas

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Plos One|July 2, 2009
Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosusAlexander R Abbas, Kristen Wolslegel, Dhaya Seshasayee, et al.
Journal of Hepatocellular Carcinoma|October 18, 2022
Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular CarcinomaAhmed O Kaseb, Yinghui Guan, Betul Gok Yavuz, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2009
T-helper type 2-driven inflammation defines major subphenotypes of asthmaPrescott G Woodruff, Barmak Modrek, David F Choy, et al.
Arthritis and Rheumatism|July 27, 2012
Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation studyJacqueline M McBride, Jenny Jiang, Alexander R Abbas, et al.
Inflammatory Bowel Diseases|September 18, 2010
Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysisColin L Noble, Alexander R Abbas, Charles W Lees, et al.
Nature Medicine|February 12, 2008
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogensYan Zheng, Patricia A Valdez, Dimitry M Danilenko, et al.
Arthritis and Rheumatism|April 21, 2011
Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosusAlyssa M Morimoto, Donna Thibault Flesher, Jihong Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2010
Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airwaysDavid F Choy, Barmak Modrek, Alexander R Abbas, et al.
Lupus Science & Medicine|April 11, 2015
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLEWilliam P Kennedy, Romeo Maciuca, Kristen Wolslegel, et al.
Mbio|May 25, 2017
Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic <i>Escherichia coli</i> IsolateJingyu Diao, Catrien Bouwman, Donghong Yan, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Plos One|July 2, 2009
Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosusAlexander R Abbas, Kristen Wolslegel, Dhaya Seshasayee, et al.
Journal of Hepatocellular Carcinoma|October 18, 2022
Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular CarcinomaAhmed O Kaseb, Yinghui Guan, Betul Gok Yavuz, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2009
T-helper type 2-driven inflammation defines major subphenotypes of asthmaPrescott G Woodruff, Barmak Modrek, David F Choy, et al.
Arthritis and Rheumatism|July 27, 2012
Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation studyJacqueline M McBride, Jenny Jiang, Alexander R Abbas, et al.
Inflammatory Bowel Diseases|September 18, 2010
Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysisColin L Noble, Alexander R Abbas, Charles W Lees, et al.
Nature Medicine|February 12, 2008
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogensYan Zheng, Patricia A Valdez, Dimitry M Danilenko, et al.
Arthritis and Rheumatism|April 21, 2011
Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosusAlyssa M Morimoto, Donna Thibault Flesher, Jihong Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2010
Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airwaysDavid F Choy, Barmak Modrek, Alexander R Abbas, et al.
Lupus Science & Medicine|April 11, 2015
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLEWilliam P Kennedy, Romeo Maciuca, Kristen Wolslegel, et al.
Mbio|May 25, 2017
Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic <i>Escherichia coli</i> IsolateJingyu Diao, Catrien Bouwman, Donghong Yan, et al.
Pageof 3